News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,174 Results
Type
Article (5889)
Company Profile (71)
Press Release (230122)
Section
Business (81384)
Career Advice (131)
Deals (13256)
Drug Delivery (11)
Drug Development (35144)
Employer Resources (12)
FDA (4074)
Job Trends (4120)
News (122795)
Policy (8739)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (310)
Accelerated approval (20)
ADA (11)
Allergies (79)
Alliances (17088)
ALS (92)
Alzheimer's disease (599)
Antibody-drug conjugate (ADC) (282)
Approvals (4537)
Artificial intelligence (186)
ASCO (108)
Autoimmune disease (179)
Automation (10)
Bankruptcy (63)
Belgium (2)
Best Places to Work (3556)
BIO (28)
Biologics (8)
BIOSECURE Act (2)
Biosimilars (161)
BioSpace Insights (6)
Biotechnology (50)
Bladder cancer (86)
Brain cancer (28)
Breast cancer (239)
Cancer (2390)
Cardiovascular disease (146)
Career advice (120)
Career pathing (4)
CAR-T (119)
CDC (3)
CDMO (26)
Celiac Disease (2)
Cell therapy (278)
Cervical cancer (16)
Clinical research (33128)
Collaboration (902)
Commercialization (4)
Compensation (952)
Complete response letters (25)
COVID-19 (589)
CRISPR (33)
C-suite (597)
Cystic fibrosis (46)
Data (3973)
Depression (84)
Dermatology (51)
Diabetes (209)
Diagnostics (1236)
Digital health (12)
Diversity, equity & inclusion (2)
Drug discovery (116)
Drug pricing (14)
Drug shortages (5)
Duchenne muscular dystrophy (109)
Earnings (38424)
Editorial (4)
Employer branding (1)
Employer resources (11)
Events (40853)
Executive appointments (483)
FDA (5918)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (564)
Gene editing (60)
Generative AI (12)
Gene therapy (156)
GLP-1 (350)
Government (663)
Grass and pollen (1)
Guidances (274)
Healthcare (3526)
Hematology (80)
HIV (41)
Huntington's disease (12)
IgA nephropathy (54)
Immunology and inflammation (77)
Immuno-oncology (42)
Indications (113)
Infectious disease (684)
Inflammatory bowel disease (94)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (132)
Interviews (21)
IPO (7331)
IRA (4)
Job creations (738)
Job search strategy (105)
JPM (5)
Kidney cancer (17)
Kidney disease (41)
Labor market (3)
Layoffs (44)
Leadership (5)
Legal (1573)
Licensing (17)
Liver cancer (42)
Longevity (11)
Lung cancer (421)
Lymphoma (223)
Machine learning (17)
Management (4)
Manufacturing (439)
Marketing (9)
MASH (136)
Medical affairs (1)
Medical device (2150)
Medtech (2189)
Mergers & acquisitions (6591)
Metabolic disorders (615)
mRNA (27)
Multiple sclerosis (89)
NASH (7)
Netherlands (2)
Neurodegenerative disease (140)
Neuropsychiatric disorders (43)
Neuroscience (1286)
NextGen: Class of 2026 (1034)
Non-profit (297)
Now hiring (4)
Obesity (241)
Opinion (33)
Ovarian cancer (71)
Pain (81)
Pancreatic cancer (101)
Parkinson's disease (140)
Partnered (6)
Patents (246)
Patient recruitment (385)
Patient selection (4)
Peanut (25)
People (19781)
Peptides (3)
Pharmaceutical (22)
Pharmacy benefit managers (5)
Phase 1 (9667)
Phase 2 (14772)
Phase 3 (11231)
Pipeline (5491)
Policy (20)
Postmarket research (696)
Preclinical (3593)
Press Release (14)
Prostate cancer (110)
Psychedelics (5)
Radiopharmaceuticals (147)
Rare diseases (418)
Real estate (1431)
Recruiting (7)
Regenerative medicine (1)
Regulatory (8746)
Reports (22)
Research institute (330)
Resumes & cover letters (11)
Rett syndrome (4)
RNA editing (6)
RSV (19)
Schizophrenia (131)
Series A (100)
Series B (76)
Service/supplier (2)
Sickle cell disease (40)
Spinal muscular atrophy (53)
Sponsored (6)
Startups (1053)
State (1)
Stomach cancer (2)
Substance use disorders (12)
Supply chain (30)
Tariffs (8)
Vaccines (210)
Venture capital (15)
Weight loss (88)
Women's health (27)
Worklife (1)
Date
Today (42)
Last 7 days (159)
Last 30 days (942)
Last 365 days (12251)
2026 (8870)
2025 (12086)
2024 (13992)
2023 (16149)
2022 (20890)
2021 (22072)
2020 (19345)
2019 (12675)
2018 (9379)
2017 (11161)
2016 (9464)
2015 (12168)
2014 (9230)
2013 (6962)
2012 (7046)
2011 (7168)
2010 (6945)
Location
Africa (157)
Alabama (24)
Arizona (71)
Arkansas (3)
Asia (29162)
Australia (3680)
California (6096)
Canada (1444)
China (1270)
Colorado (222)
Connecticut (286)
Delaware (275)
Europe (35294)
Florida (898)
Georgia (197)
Hawaii (1)
Idaho (4)
Illinois (363)
India (69)
Indiana (238)
Iowa (13)
Japan (470)
Kansas (83)
Kentucky (15)
Louisiana (17)
Maine (11)
Maryland (594)
Massachusetts (4825)
Michigan (76)
Minnesota (234)
Mississippi (2)
Missouri (40)
Montana (4)
Nebraska (7)
Nevada (36)
New Hampshire (14)
New Jersey (2130)
New Mexico (4)
New York (1824)
North Carolina (760)
Northern California (3307)
Ohio (158)
Oklahoma (8)
Oregon (11)
Pennsylvania (1104)
Puerto Rico (5)
Rhode Island (4)
South America (220)
South Carolina (7)
Southern California (2423)
Tennessee (40)
Texas (695)
United States (21644)
Utah (160)
Vermont (1)
Virginia (245)
Washington D.C. (17)
Washington State (397)
Wisconsin (40)
Wyoming (1)
236,174 Results for "intas biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India
February 10, 2026
·
3 min read
Press Releases
Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India
March 23, 2026
·
5 min read
Press Releases
SK Biopharmaceuticals to In-License Epilepsy Drug Candidate ‘Opakalim’
August 26, 2026
·
15 min read
Intas & Accord signs Agreement to acquire Prothya Biosolutions
August 12, 2025
·
3 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
Medicinal Technologies Advances Commercial and Regulatory Infrastructure in the Emerging Over-the-Counter Biopharmaceutical Sector
September 14, 2026
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results 2026
August 19, 2026
·
2 min read
Press Releases
Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in Canada
October 10, 2025
·
6 min read
Press Releases
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
September 17, 2026
·
6 min read
1 of 23,618
Next
